PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1164920
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1164920
Hematology Analyzers and Reagent Market size was valued at USD 2,230.7 Million in 2021, expanding at a CAGR of 11.6% from 2022 to 2028.
Hematology reagents are very essential in the use of a hematology analyzer. Such hematology reagents include hemolytic agents, diluents, cleaning solutions, and concentrated cleaning solutions. hematology analyzers are used to enhance medical laboratory operations and improve patient care.
The demand for hematology analyzers and reagents is anticipated to increase over the forecast period as a result of rising adoption rates for automated hematology instruments and rising preferences for high-sensitivity point-of-care (POC) hematology testing. Rapid technical development, including the introduction of fundamental flow cytometry techniques and the creation of high throughput hematology analyzers, is also anticipated to have a significant impact on this industry. The hematology analyzers and reagents market is also anticipated to increase as a result of technological improvements and advancements such as the integration of hematology analyzers with flow cytometry instruments. However, the growth is constrained by a lack of preference leading to a slow rate of adoption of this equipment in the developing globe.
The main driver fueling the growth of the hematology analyzers and reagents market is rising blood donation volumes along with a high prevalence of blood diseases. Asia-Pacific is anticipated to experience a substantial growth rate during the forecast period because these governments have implemented favorable rules and compliances for the use of innovative medical equipment. COVID-19 has had a positive impact on the market as the rising health concerns have increased the adoption of advanced medical instrumentation solutions.
The Global Hematology Analyzers and Reagent Market is segmented on the basis of Product Type, End User, and Region.
The market is divided into two categories based on Product Type: analyzers and reagents. The analyzers segment dominates the market. Increasing demand for hematology analyzers in the medical industry is boosting segment growth.
The market is divided into four categories based on end-user: hospitals and clinics, diagnostic laboratories, research institutes, and others. The hospitals and clinics segment dominates the market and is likely to maintain its dominance during the forecast period. This is partly due to an increase in the prevalence of blood-related disorders.
The global hematology analyzers and reagent market are extremely consolidated in nature with the few players dominating the market with the largest market share. Several companies are indulging in various strategic initiatives such as developing novel technologies to meet the requirements of the end-users. Some of the primary techniques used by corporations to strengthen their reach and expand their market share include new product launches, partnerships, distribution network development, R&D spending, and mergers and acquisitions.
For instance, in October 2021, Sysmex America introduced the first hematology analyzer for malaria detection namely XN-30. Specialized reagents, a violet laser, and advanced algorithms allow the XN-30 RUO to differentiate P. falciparum from non-falciparum species and determine the life cycle staging of the parasites detected.
This proposed research study on Hematology Analysers and Reagent market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2022-2028), considering 2021 as the base year
The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Hematology Analyzers and Reagent market
The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Hematology Analyzers and Reagent market
Impact of COVID-19 on Hematology Analyzers and Reagent market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Hematology Analyzers and Reagent market post-COVID will also be covered.
In order to give the users of this report a comprehensive view on the Hematology Analyzers and Reagent market, we have also included competitive landscape and key innovator analysis for the Hematology Analyzers and Reagent market.
The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Hematology Analyzers and Reagent market.
In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
The global Hematology Analyzers and Reagent market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
The scope of this report covers the market by its major segments, which include as follows:
Beckman Coulter
Sysmex Corporation
HORIBA Ltd
Abbott Laboratories
Diatron
Danaher
Bio-Rad Laboratories
Siemens AG
Mindray Medical International Limited
Boule Diagnostics AB
Roche Diagnostics
Nihon Kohden Corporation
GLOBAL HEMATOLOGY ANALYZERS AND REAGENT MARKET, BY PRODUCT TYPE
Analyzers
Reagents
GLOBAL HEMATOLOGY ANALYZERS AND REAGENT MARKET, BY END USER
Hospitals and clinics
Diagnostic laboratories
Research institutes
Others
GLOBAL HEMATOLOGY ANALYZERS AND REAGENT MARKET, BY REGION
North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA